Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis

Hepatology Research

Volumn 41, Issue 10, 2011, Pages 965-970

  Akima, Takashi ^a   Tamano, Masaya ^a   Hiraishi, Hideyuki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Transient elastography; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; BILIRUBIN; DECARBOXYPROTHROMBIN; INTERFERON; PROTHROMBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ELASTOGRAPHY; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE COUNT;

EID: 80053286507     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00846.x     Document Type: Article

References (23)

1. Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006; 43: 373-4.
2. Foucher J, Chanteloup E, Vergniol J etal. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
3. Ganne-Carrie N, Ziol M, de Ledinghen V etal. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-17.
4. Friedrich-Rust M, Ong MF, Herrmann E etal. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188: 758-64.
5. Ogawa E, Furusyo N, Toyoda K etal. Transient elastography for patients with chronic hepatitis B and C virus infection: non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 2007; 37: 1002-10.
6. Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, Nakajima A. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1.
7. Yoneda M, Mawatari H, Fujita K etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 371-8.
8. Nitta Y, Kawabe N, Hashimoto S etal. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 2009; 39: 675-84.
9. Masuzaki R, Tateishi R, Yoshida H etal. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol 2008; 42: 839-43.
10. Masuzaki R, Tateishi R, Yoshida H etal. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-61.
11. Nahon P, Kettaneh A, Lemoine M etal. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study. Eur J Gastroenterol Hepatol 2009; 21: 214-9.
12. Fung J, Lai CL, Seto WK, Wong DK, Yuen MF. Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B. J Viral Hepat 2010; 26: In Press.
13. Kuo YH, Lu SN, Hung CH etal. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int 2010; 4: 700-6.
14. Sandrin L, Fourquet B, Hasquenoph JM etal. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
15. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744-9.
16. Regev A, Berho M, Jeffers LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-18.
17. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
18. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68, 276 biopsies. J Hepatol 1986; 2: 165-73.
19. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995; 22: 22-6.
20. Pares A, Deulofeu R, Gimenez A etal. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24: 1399-403.
21. Enomoto M, Mori M, Ogawa T etal. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy. Hepatol Res 2010; 40: 853-61.
22. Arima Y, Kawabe N, Hashimoto S etal. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. Hepatol Res 2010; 40: 383-92.
23. Laurent TC, Laurent UB, Fraser JR. Serum hyaluronan as a disease marker. Ann Med 1996; 28: 241-53.